Blue Heron Gets New CEO; Genomic Health OKs ’07 Salaries for Brass; Proteopure Names Invitrogen Alumnus to Board; and Others | GenomeWeb
NEW YORK (GenomeWeb News) — Ambit Biosciences, a small-molecule kinase-development company, has appointed Kerry Kelly to the position of vice president and general counsel, the company said Tuesday. Kelly recently was associate general counsel for The Scripps Research Institute and before that she was head of corporate affairs for biotech company Sugen, which has since been acquired by Pfizer.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.